Optimal timing and dosing intervals of palivizumab in premature neonates: still some work to do
- PMID: 15867062
- DOI: 10.1542/peds.2004-2865
Optimal timing and dosing intervals of palivizumab in premature neonates: still some work to do
Comment on
-
Palivizumab use in very premature infants in the neonatal intensive care unit.Pediatrics. 2004 Nov;114(5):e554-6. doi: 10.1542/peds.2004-0226. Pediatrics. 2004. PMID: 15520088 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical